PharmacOdynamic compaRison of piTavastatin Versus atOrvastatin on Platelet Reactivity

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT01648829

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose diagnostic
Phase
Phase 4
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01648829
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Italy (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01648829. Randomized; quadruple masking; primary purpose diagnostic. Start 2014-01 (registry gives no type); primary completion 2015-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
PharmacOdynamic compaRison of piTavastatin Versus atOrvastatin on Platelet Reactivity
Acronym
PORTO
Intervention (Drug)
Atorvastatin
Intervention (Drug)
Pitavastatin
Lead sponsor
University of Roma La Sapienza (class: other)

Record details

Record id
cardio:ct-nct01648829
Content hash
dbf5d71779760cb2476365505c019834d333fa9136cb92118565ec701c630e6f